Johnny Cheng appointed as interim CEO of HUTCHMED
Written by
PharmaTimes
Published
0
comments
0
min
HUTCHMED has announced that Weiguo Su, CEO of the company, will take a leave of absence from his duties due to health reasons. As a result, the board of directors has appointed Johnny Cheng, an executive director and chief financial officer (CFO) of the company, as acting CEO with immediate effect, in addition to his […]